Which Tarbell fans are making a difference right now?
Pioneering journalism that informs, galvanizes and changes America.
Tarbell uncovers how powerful people and companies use their influence to shape a system that works for them, not you. We highlight solutions to pressing problems. Our fiercely independent, unbiased news inspires people in all 50 U.S. states to take action.
We understand there are stories that matter to all Americans. We believe there’s journalism that can inspire people to see how much we agree. We know people want actionable, evidence-based solutions.
Have a question or tip for a story? Email questions@tarbell.org. Want to work with us? Email hello@tarbell.org.
Across the country, expanding the dental workforce to include dental therapists is one of a very few health care proposals that attracts support from lawmakers in both parties.
Yes, Novartis secretly paid Trump lawyer Michael Cohen $1.2 million to gain insights into the president’s thinking on health care. But there is more to it.
Thirty-six state attorneys general and others allege that the manufacturer of Suboxone, a balm for America’s opioid crisis, gamed regulators and manipulated the market to overcharge consumers.
The drug industry worked with the Obama administration to sow safety fears about cheaper medications from foreign sources.
6 ways you can spot biased research and help expose false findings.
Many organizations demand transparency about funders and authors of industry-backed studies.
What we learned: Why you should be concerned some scientists bias their results to benefit their corporate funders over the public welfare.
What you can do: Join Tarbell in finding false, industry-funded research.
What we learned: Research funded by companies pervades government policy making and regulatory agencies. Slanted and misleading data has a long history of helping corporate bottom lines while endangering public health and welfare.
What you can do: Learn to spot a suspect study by asking the right five questions.
What we learned: How to spot research that is biased to support corporate profits over people.
What you can do: Educate yourself by researching how products you use, like prescription drugs, have caused harm to others.
Learn about efforts already underway to improve government transparency.
5 ways you can take action in response to the new tax law.
What we found: An eleventh-hour inclusion of provisions to the GOP Tax Law (thanks to the petrochemical industry) allowed drilling in the Arctic National Wildlife Refuge.
What you can do: Connect with the Sunlight Foundation’s government transparency efforts.
What we learned: Real estate lobbyists won a hefty tax break in the new tax law.
What you can do: Discover the focus on good government ethics pursued by the Foundation for Accountability and Civic Trust.
What we learned: Hedge fund lobbyists secured a $2 billion tax break for a handful of their clients.
What you can do: Learn about the R Street Institute’s work to promote free market growth through open government.
What we learned: How the U.S. Chamber of Commerce out-organized opponents to pass the new tax law.
What you can do: Find out who is filling your representatives’ pockets thanks to Open Secrets.
Embracing them requires creativity, courage and a willingness to buck Big Pharma’s status quo.
8 ways you can take action on high drug costs.
What we learned: High drug prices hurt real people every day.
What you can do: Share the stories of people affected by high drug prices.
What we learned: Pharma’s concerns about drug safety have stalled efforts to import cheaper drugs.
What you can do: Import cheaper Canadian drugs yourself through PharmacyChecker.com.
What we learned: Unlike other countries, the U.S. government cannot negotiate lower drug prices.
What you can do: Connect with AARP’s effort to allow Medicare to negotiate drug prices.
What we learned: Manufacturers find advantages in the Orphan Drug Act and intellectual property protections to keep prices high.
What you can do: Support efforts to make the regulation and pricing of drugs more transparent.
And why we’re far from done investigating high drug prices.
Critics call it a “coup d’etat” of America’s health care system by pharmaceutical companies.
What we learned: PhRMA paid $14.3 million to think tanks, disease advocacy groups and universities. The money buys both assistance and silence.
What you can do: Call the drug industry trade group at 202-835-3400.